valsartan
-
Novartis Granted Pediatric Indication for Hypertension Treatment
The European Commission (EC) has granted Diovan (valsartan) a pediatric indication for the treatment of hypertension in children and adolescents 6-18 years of age. Following the Commission's decision, the pediatric indication needs to be implemented …
valsartan | 13 May 2010
